Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep;50(9):3000605221123882.
doi: 10.1177/03000605221123882.

Refractory postherpetic neuralgia in a multiple myeloma patient with lenalidomide maintenance therapy: a case report

Affiliations
Case Reports

Refractory postherpetic neuralgia in a multiple myeloma patient with lenalidomide maintenance therapy: a case report

Xueqin Cao et al. J Int Med Res. 2022 Sep.

Abstract

Herpes zoster is not common in multiple myeloma (MM) patients treated with lenalidomide-based regimens. We report an MM patient in his late 60s who received lenalidomide as maintenance treatment and whose condition was complicated with refractory postherpetic neuralgia. The patient received antiviral treatment and analgesia immediately after the diagnosis of herpes zoster. Two months later, the patient received acupuncture, radiofrequency treatment, and even spinal cord stimulation, which failed to relieve the pain. Consequently, we performed high-resolution magnetic resonance imaging of the cervical and thoracic nerves. Then, stellate ganglion block, left C5/C6/C7/C8 nerve root block, and left thoracic 1, 2 paravertebral nerve block were performed with the assistance of real-time ultrasound. The pain was immediately relieved after treatment; however, the symptoms reappeared 2 days later. At 5 months after treatment, the patient still experienced severe pain. We suggest that MM patients complicated with postherpetic neuralgia are refractory to treatment. Starting nerve block therapy, pulsed radiofrequency, and other interventional therapies as early as possible could be a more optimal treatment plan for these patients.

Keywords: Postherpetic neuralgia; chemotherapy-induced periphery neuropathy; herpes zoster; lenalidomide; multiple myeloma; pain.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Sensory test of skin with herpes scars. (a) Allodynia mainly occurred in the left back and left upper arm where herpes scars were located and (b) Numbness was mainly distributed in the skin innervated by the median and ulnar nerves. The blue dotted box shows the area affected by allodynia; the green dotted box shows the area affected by numbness.
Figure 2.
Figure 2.
High-resolution magnetic resonance imaging of the cervical nerves. (a) The left C5/C6/C7/C8 dorsal root ganglia were substantially enlarged, and the corresponding nerve roots were obviously swollen and (b) The median nerve was degenerated; the arrows indicate the median nerve.
Figure 3.
Figure 3.
Magnetic resonance imaging of the cervical spine. (a) A mild cervical disc herniation at C3/4, C4/5, C5/6, and C6/7 and (b) No obvious symptoms of nerve compression were observed.

References

    1. Marra F, Parhar K, Huang B, et al.. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis 2020; 7: a5. - PMC - PubMed
    1. Peng WW, Guo XL, Jin QQ, et al.. Biological mechanism of post-herpetic neuralgia: evidence from multiple patho-psychophysiological measures. Eur J Pain 2017; 21: 827–842. - PubMed
    1. Bechakra M, Nieuwenhoff MD, Van Rosmalen J, et al.. Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain. Mol Pain 2018; 14: 2070366478. - PMC - PubMed
    1. Dalla TC, Zambello R, Cacciavillani M, et al.. Lenalidomide long-term neurotoxicity: clinical and neurophysiologic prospective study. Neurology 2016; 87: 1161–1166. - PubMed
    1. Gagnier JJ, Kienle G, Altman DG, et al.; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache 2013; 53: 1541–1547. - PubMed

Publication types

MeSH terms